Prevalence of retinopathy in Finnish children and adolescents with type 1 diabetes: a cross-sectional population-based retrospective study

2011 ◽  
Vol 96 (10) ◽  
pp. 963-968 ◽  
Author(s):  
M. Kubin ◽  
P. Tossavainen ◽  
V. Hannula ◽  
S. Lahti ◽  
N. Hautala ◽  
...  
Nutrients ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 3052
Author(s):  
Chiara Mameli ◽  
Camilla Cattaneo ◽  
Luisa Lonoce ◽  
Giorgio Bedogni ◽  
Francesca Chiara Redaelli ◽  
...  

Type 1 diabetes (T1D) is one of the most common systemic diseases in childhood which predisposes the patient to serious short-term and long-term complications, affecting all body systems. Taste and olfactory impairments were first described a long time ago in adult patients affected by diabetes (both type 1 and type 2 diabetes). However, studies evaluating taste perception, behavioral attitudes (e.g., food neophobia), and preferences toward foods in children and adolescents affected by T1D are globally lacking. Therefore, the purpose of this study was to assess taste sensitivity, food neophobia, and preferences among children and adolescents affected by T1D and healthy controls in a cross-sectional study. T1D patients presented a significantly lower ability in general to correctly identify taste qualities, especially bitter and sour tastes. Moreover, they were characterized by fewer fungiform papillae compared to controls, as well as a lower responsiveness to the bitter compound 6-n-propylthiouracil (PROP). There were no significant differences in food neophobia scores between the two groups, but differences were observed in the mean hedonic ratings for some product categories investigated. Diabetic patients showed a greater liking for certain type of foods generally characterized by sourness and bitterness, an observation probably linked to their impaired ability to perceive taste stimuli, e.g., sourness and bitterness. These results may help to enhance the understanding of these relationships in populations with elevated diet-related health risks.


2012 ◽  
Vol 14 (1) ◽  
pp. 13-17 ◽  
Author(s):  
Michael Joseph O'Grady ◽  
Joanna Delaney ◽  
Timothy William Jones ◽  
Elizabeth Ann Davis

2010 ◽  
Vol 12 (1) ◽  
pp. 4-10 ◽  
Author(s):  
Annalisa Blasetti ◽  
Concetta Di Giulio ◽  
Anna Maria Tocco ◽  
Alberto Verrotti ◽  
Stefano Tumini ◽  
...  

2020 ◽  
Author(s):  
Katarzyna Anna Gajewska ◽  
Kathleen Bennett ◽  
Regien Biesma ◽  
Seamus Sree

Abstract Background: The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type 1 diabetes varies internationally and is mainly determined by the national healthcare reimbursement systems. The aim of this study is to estimate national and regional uptake of CSII therapy in children, adolescents and adults with type 1 diabetes in Ireland. Methods: A retrospective cross-sectional study was conducted utilizing the national pharmacy claims database in 2016. Individuals using CSII were identified by dispensing of infusion sets. The uptake of CSII was calculated as the percentage of people with type 1 diabetes claiming CSII sets in 2016, both in children and adolescent (age <18 years) and adult populations (≥18 years). Descriptive statistics including percentages with 95% confidence intervals (CIs) are presented, stratified by age-groups and geographical regions, and chi-square tests used for comparisons. Results: Of 20,081 people with type 1 diabetes, 2,111 (10.5%, 95%CI: 10.1%-10.9%) were using CSII in 2016. Uptake was five-fold higher in children and adolescents at 34.7% (95%CI: 32.9%-36.5%) than in adults at 6.8% (95%CI: 6.4%-7.2%). Significant geographical heterogeneity in CSII uptake was found, from 12.6% to 53.7% in children and adolescents (p<0.001), and 2% to 9.6% in adults (p<0.001). Conclusions: Uptake of CSII in people with type 1 diabetes is low in Ireland, particularly in those ≥18 years. Identification of barriers to uptake, particularly in this group, is required.


Sign in / Sign up

Export Citation Format

Share Document